Review: Methotrexate does not increase risk for lung disease in psoriasis, psoriatic arthritis, or IBD

被引：0
|
作者：
Smith, Malcolm D. [1 ]
机构：
[1] Repatriat Gen Hosp, Adelaide, SA, Australia
来源：
ANNALS OF INTERNAL MEDICINE | 2015年 / 163卷 / 02期
关键词：
TOXICITY;
D O I：
10.7326/ACPJC-2015-163-2-007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risk of Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis Treated with Methotrexate
    Wan, Joy
    Zhang, He
    Ogdie, Alexis
    Egeberg, Alexander
    Gelfand, Joel M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 12 - 12
  • [2] Risk of psoriatic arthritis in psoriasis patients on biologics and methotrexate
    Lininger, E. N.
    Siegel, S. A.
    Winthrop, K. L.
    Deodhar, A.
    Kiwalkar, S.
    Ortega-Loayza, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S63 - S63
  • [3] Methotrexate use in psoriasis and psoriatic arthritis
    Cuellar, ML
    Espinoza, LR
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1997, 23 (04) : 797 - &
  • [4] Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials
    Conway, Richard
    Low, Candice
    Coughlan, Robert J.
    O'Donnell, Martin J.
    Carey, John J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [5] Psoriasis, psoriatic arthritis, or psoriatic disease?
    Scarpa, R
    Ayala, F
    Caporaso, N
    Olivieri, I
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 210 - 212
  • [6] Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis
    Barbarroja, Nuria
    Arias-de la Rosa, Ivan
    Lopez-Medina, Clementina
    del Rosario Camacho-Sanchez, Maria
    Gomez-Garcia, Ignacio
    Jose Velez-Garcia, Antonio
    Escudero-Contreras, Alejandro
    Lopez-Pedrera, Chary
    Dolores Lopez-Montilla, Maria
    Collantes-Estevez, Eduardo
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2019, 11
  • [7] Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study
    Gelfand, Joel M.
    Wan, Joy
    Zhang, He
    Shin, Daniel B.
    Ogdie, Alexis
    Syed, Maha N.
    Egeberg, Alexander
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (06) : 1636 - 1643
  • [8] Methotrexate in the treatment of severe psoriasis (psoriatic arthritis, erythrodermic psoriasis, pustular psoriasis)
    Omar, B. S.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 8 - 8
  • [9] Methotrexate use and liver outcomes in psoriasis and rheumatoid arthritis patients: A commentary on "Risk of liver disease in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis receiving methotrexate: A population-based study''
    Gau, Shuo-Yan
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (06) : E399 - E400
  • [10] Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis
    Tobin, Anne-Marie
    Veale, Douglas J.
    Fitzgerald, Oliver
    Rogers, Sarah
    Collins, Paul
    O'Shea, Donal
    Kirby, Brian
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1386 - 1394
12345